Ge Xingtao, Zhou Gang
Department of Orthopedics 4, Rizhao People's Hospital Rizhao, Shandong Province, China.
Department of Orthopedic Surgery, Hainan General Hospital Haikou, Hainan Province, China.
Am J Transl Res. 2021 Jun 15;13(6):6330-6341. eCollection 2021.
To investigate the protective effects of Naringin on glucocorticoid-induced osteoporosis (GIOP) through the PI3K/AKT/mTOR signaling pathway in vivo and in vitro.
Osteoblasts were cultured from the differentiated bone marrow mesenchymal stem cells (BM-MSCs) and were grouped as follows: the PBS group (the control group), the model group (Dexamethasone intervention), the LY294002 group (PI3K/AKT/mTOR pathway inhibitor intervention), the Naringin group (Naringin intervention), and the LY294002+ Naringin intervention group. Cell proliferation and differentiation were detected through cell counting kit-8 (CCK8) assay and alkaline phosphatase (ALP) staining, respectively. The formation of autophagosome was observed by Monodansylcadaverine (MDC) staining. Expressions of signaling pathway and autophagy related factors such as Beclin-1 and p62 were detected by qRT-PCR and western blot. Then, the rats were grouped as the PBS group (normal rats injected with PBS), the model group (GIOP rats injected with dexamethasone), the LY294002 group (GIOP rats injected with PI3K/AKT/mTOR pathway inhibitor LY294002), the Naringin group (GIOP rats injected with Naringin) and the LY294002+ Naringin group (GIOP rats injected with PI3K/AKT/mTOR pathway inhibitor LY294002 and Naringin). Bone mineral density and bone histomorphometry parameters of rats in each group were compared. In addition, the expressions of pathway and autophagy related factors in cartilage tissue of rats in each groups were also detected.
The proliferation and differentiation abilities of osteoblasts were increased with an increasing concentration of Naringin in a dose-dependent manner. Compared with the model group, the expression of PI3K/AKT/mTOR pathway related phosphorylated proteins, the proliferation and differentiation abilities of osteoblasts, the expression of autophagosome and autophagy related factors were all increased in the Naringin group, but contrary results were found in the LY294002 group (all P<0.05). In vivo, GIOP rats had improved bone mineral density and bone morphology parameters , and elevated expressions of autophagy related factors in cartilage tissue compared to the model group through Naringin intervention, while LY294002 intervention showed the opposite effects (all P<0.05). What is more, LY294002 partially reversed the effects of Naringin on osteogenic differentiation and bone morphological parameters in GIOP.
Naringin exerts protective effects in GIOP by the PI3K/AKT/mTOR pathway, which may be related to autophagy induction and enhanced proliferation of osteoblasts.
通过体内外实验,研究柚皮苷通过PI3K/AKT/mTOR信号通路对糖皮质激素诱导的骨质疏松症(GIOP)的保护作用。
从分化的骨髓间充质干细胞(BM-MSCs)中培养成骨细胞,并分为以下几组:PBS组(对照组)、模型组(地塞米松干预)、LY294002组(PI3K/AKT/mTOR通路抑制剂干预)、柚皮苷组(柚皮苷干预)和LY294002 + 柚皮苷干预组。分别通过细胞计数试剂盒-8(CCK8)法和碱性磷酸酶(ALP)染色检测细胞增殖和分化。通过单丹磺酰尸胺(MDC)染色观察自噬体的形成。通过qRT-PCR和蛋白质免疫印迹法检测Beclin-1和p62等信号通路和自噬相关因子的表达。然后,将大鼠分为PBS组(注射PBS的正常大鼠)、模型组(注射地塞米松的GIOP大鼠)、LY294002组(注射PI3K/AKT/mTOR通路抑制剂LY294002的GIOP大鼠)、柚皮苷组(注射柚皮苷的GIOP大鼠)和LY294002 + 柚皮苷组(注射PI3K/AKT/mTOR通路抑制剂LY294002和柚皮苷的GIOP大鼠)。比较各组大鼠的骨密度和骨组织形态计量学参数。此外,还检测了各组大鼠软骨组织中信号通路和自噬相关因子的表达。
随着柚皮苷浓度的增加,成骨细胞的增殖和分化能力呈剂量依赖性增加。与模型组相比,柚皮苷组PI3K/AKT/mTOR通路相关磷酸化蛋白的表达、成骨细胞的增殖和分化能力、自噬体和自噬相关因子的表达均增加,但LY294002组结果相反(均P<0.05)。在体内,与模型组相比,柚皮苷干预可改善GIOP大鼠的骨密度和骨形态参数,并提高软骨组织中自噬相关因子的表达,而LY294002干预则显示相反的效果(均P<0.05)。此外,LY29400部分逆转了柚皮苷对GIOP大鼠成骨分化和骨形态参数的影响。
柚皮苷通过PI3K/AKT/mTOR通路对GIOP发挥保护作用,这可能与诱导自噬和增强成骨细胞增殖有关。